NDC product
Gammaplex
NDC 64208-8235 · Bio Products Laboratory Ltd
Key facts
| Product NDC | 64208-8235 |
|---|---|
| Proprietary name | Gammaplex |
| Nonproprietary name | HUMAN IMMUNOGLOBULIN G |
| Substances | HUMAN IMMUNOGLOBULIN G |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Labeler | Bio Products Laboratory Ltd |
| Product type | PLASMA DERIVATIVE |
| Marketing category | BLA |
| Application number | BLA125329 |
| Pharmacologic classes | Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE] |
| Marketing start | Apr 7, 2017 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: